229 related articles for article (PubMed ID: 23056236)
1. 3D models of MBP, a biologically active metabolite of bisphenol A, in human estrogen receptor α and estrogen receptor β.
Baker ME; Chandsawangbhuwana C
PLoS One; 2012; 7(10):e46078. PubMed ID: 23056236
[TBL] [Abstract][Full Text] [Related]
2. Repeated Exposure to 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), an Active Metabolite of Bisphenol A, Aggressively Stimulates Breast Cancer Cell Growth in an Estrogen Receptor
Hirao-Suzuki M; Takeda S; Okuda K; Takiguchi M; Yoshihara S
Mol Pharmacol; 2019 Mar; 95(3):260-268. PubMed ID: 30552153
[TBL] [Abstract][Full Text] [Related]
3. Repeated exposure to 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) accelerates ligand-independent activation of estrogen receptors in long-term estradiol-deprived MCF-7 cells.
Hirao-Suzuki M; Takiguchi M; Yoshihara S; Takeda S
Toxicol Lett; 2023 Apr; 378():31-38. PubMed ID: 36863540
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonist.
Maruyama K; Nakamura M; Tomoshige S; Sugita K; Makishima M; Hashimoto Y; Ishikawa M
Bioorg Med Chem Lett; 2013 Jul; 23(14):4031-6. PubMed ID: 23768907
[TBL] [Abstract][Full Text] [Related]
5. 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) Targets Estrogen Receptor β, to Evoke the Resistance of Human Breast Cancer MCF-7 Cells to G-1, an Agonist for G Protein-Coupled Estrogen Receptor 1.
Hirao-Suzuki M; Nagase K; Suemori T; Tsutsumi K; Shigemori E; Tanaka M; Takiguchi M; Sugihara N; Yoshihara S; Takeda S
Biol Pharm Bull; 2021; 44(10):1524-1529. PubMed ID: 34602561
[TBL] [Abstract][Full Text] [Related]
6. Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone through estrogen receptor α and β in vitro.
Li Y; Burns KA; Arao Y; Luh CJ; Korach KS
Environ Health Perspect; 2012 Jul; 120(7):1029-35. PubMed ID: 22494775
[TBL] [Abstract][Full Text] [Related]
7. Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta.
Hiroi H; Tsutsumi O; Momoeda M; Takai Y; Osuga Y; Taketani Y
Endocr J; 1999 Dec; 46(6):773-8. PubMed ID: 10724352
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of Cancer Malignancy Elicited by Environmental Chemicals: Analysis Focusing on Cadmium and Bisphenol A].
Hirao-Suzuki M
Yakugaku Zasshi; 2022; 142(11):1161-1168. PubMed ID: 36328445
[TBL] [Abstract][Full Text] [Related]
9. Bisphenol AF is a full agonist for the estrogen receptor ERalpha but a highly specific antagonist for ERbeta.
Matsushima A; Liu X; Okada H; Shimohigashi M; Shimohigashi Y
Environ Health Perspect; 2010 Sep; 118(9):1267-72. PubMed ID: 20427257
[TBL] [Abstract][Full Text] [Related]
10. 3D models of human ERα and ERβ complexed with coumestrol.
Chandsawangbhuwana C; Baker ME
Steroids; 2014 Feb; 80():37-43. PubMed ID: 24315835
[TBL] [Abstract][Full Text] [Related]
11. 3D models of human ERα and ERβ complexed with 5-androsten-3β,17β-diol.
Baker ME; Uh KY; Chandsawangbhuwana C
Steroids; 2012 Oct; 77(12):1192-7. PubMed ID: 22921477
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo estrogenic activity of chlorinated derivatives of bisphenol A.
Takemura H; Ma J; Sayama K; Terao Y; Zhu BT; Shimoi K
Toxicology; 2005 Feb; 207(2):215-21. PubMed ID: 15596252
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Receptor β as a Possible Double-Edged Sword Molecule in Breast Cancer: A Mechanism of Alteration of Its Role by Exposure to Endocrine-Disrupting Chemicals.
Hirao-Suzuki M
Biol Pharm Bull; 2021; 44(11):1594-1597. PubMed ID: 34719637
[TBL] [Abstract][Full Text] [Related]
14. Bisphenol AF as an Inducer of Estrogen Receptor β (ERβ): Evidence for Anti-estrogenic Effects at Higher Concentrations in Human Breast Cancer Cells.
Okazaki H; Takeda S; Kakizoe K; Taniguchi A; Tokuyasu M; Himeno T; Ishii H; Kohro-Ikeda E; Haraguchi K; Watanabe K; Aramaki H
Biol Pharm Bull; 2017; 40(11):1909-1916. PubMed ID: 29093337
[TBL] [Abstract][Full Text] [Related]
15. Bisphenol-C is the strongest bifunctional ERα-agonist and ERβ-antagonist due to magnified halogen bonding.
Liu X; Suyama K; Nose T; Shimohigashi M; Shimohigashi Y
PLoS One; 2021; 16(2):e0246583. PubMed ID: 33561155
[TBL] [Abstract][Full Text] [Related]
16. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.
Bhavnani BR; Tam SP; Lu X
Endocrinology; 2008 Oct; 149(10):4857-70. PubMed ID: 18599548
[TBL] [Abstract][Full Text] [Related]
17. Bisphenol AF: Halogen bonding effect is a major driving force for the dual ERα-agonist and ERβ-antagonist activities.
Liu X; Suyama K; Shiki J; Torikai K; Nose T; Shimohigashi M; Shimohigashi Y
Bioorg Med Chem; 2020 Feb; 28(3):115274. PubMed ID: 31879182
[TBL] [Abstract][Full Text] [Related]
18. ERα-agonist and ERβ-antagonist bifunctional next-generation bisphenols with no halogens: BPAP, BPB, and BPZ.
Liu X; Matsuyama Y; Shimohigashi M; Shimohigashi Y
Toxicol Lett; 2021 Jul; 345():24-33. PubMed ID: 33857583
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled estrogen receptor activation by bisphenol-A disrupts the protection from apoptosis conferred by the estrogen receptors ERα and ERβ in pancreatic beta cells.
Babiloni-Chust I; Dos Santos RS; Medina-Gali RM; Perez-Serna AA; Encinar JA; Martinez-Pinna J; Gustafsson JA; Marroqui L; Nadal A
Environ Int; 2022 Jun; 164():107250. PubMed ID: 35461094
[TBL] [Abstract][Full Text] [Related]
20. Differential
Li Y; Perera L; Coons LA; Burns KA; Tyler Ramsey J; Pelch KE; Houtman R; van Beuningen R; Teng CT; Korach KS
Environ Health Perspect; 2018 Jan; 126(1):017012. PubMed ID: 29389661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
